Violette Shelia M. 4
4 · Q32 Bio Inc. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
Violette Shelia M.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+56,413→ 56,413 totalExercise: $16.82Exp: 2034-03-24→ Common Stock (56,413 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.